187 related articles for article (PubMed ID: 18272623)
1. Do you approve of spending $300 million on HPV vaccination?: no.
Lippman A; Boscoe M; Scurfield C
Can Fam Physician; 2008 Feb; 54(2):175, 177, 179, 181. PubMed ID: 18272623
[No Abstract] [Full Text] [Related]
2. Rebuttal: Do you approve of spending $300 million on HPV vaccination? Yes.
Steben M
Can Fam Physician; 2008 Mar; 54(3):342, 344. PubMed ID: 18337521
[No Abstract] [Full Text] [Related]
3. Do you approve of spending $300 million on HPV vaccination?: yes.
Steben M
Can Fam Physician; 2008 Feb; 54(2):174, 176, 178, 180. PubMed ID: 18272622
[No Abstract] [Full Text] [Related]
4. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
5. The quadrivalent human papillomavirus vaccine: potential factors in effectiveness.
Zonfrillo NJ; Hackley B
J Midwifery Womens Health; 2008; 53(3):188-194. PubMed ID: 18455092
[TBL] [Abstract][Full Text] [Related]
6. Rebuttal: Do you approve of spending $300 million on HPV vaccination? No.
Lippman A; Boscoe M; Scurfield C
Can Fam Physician; 2008 Mar; 54(3):343, 345. PubMed ID: 18337522
[No Abstract] [Full Text] [Related]
7. Mandating HPV vaccination: what are the arguments?
Smith CM
J Christ Nurs; 2008; 25(2):74-80; quiz 81-2. PubMed ID: 18401926
[No Abstract] [Full Text] [Related]
8. For debate: that Australia should continue using the quadrivalent vaccine.
Wain G
Sex Health; 2010 Sep; 7(3):235-7. PubMed ID: 21058496
[No Abstract] [Full Text] [Related]
9. [Cytology and DNA HPV-testing in the era of HPV-vaccine].
Spaczyński M; Malkowska-Walczak B; Nowak-Markwitz E
Ginekol Pol; 2007 Sep; 78(9):696-700. PubMed ID: 18159823
[TBL] [Abstract][Full Text] [Related]
10. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
Muñoz N; Manalastas R; Pitisuttithum P; Tresukosol D; Monsonego J; Ault K; Clavel C; Luna J; Myers E; Hood S; Bautista O; Bryan J; Taddeo FJ; Esser MT; Vuocolo S; Haupt RM; Barr E; Saah A
Lancet; 2009 Jun; 373(9679):1949-57. PubMed ID: 19493565
[TBL] [Abstract][Full Text] [Related]
11. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
Julius JM; Ramondeta L; Tipton KA; Lal LS; Schneider K; Smith JA
Pharmacotherapy; 2011 Mar; 31(3):280-97. PubMed ID: 21361739
[TBL] [Abstract][Full Text] [Related]
12. Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme.
Oteng B; Marra F; Lynd LD; Ogilvie G; Patrick D; Marra CA
Sex Transm Infect; 2011 Feb; 87(1):52-7. PubMed ID: 20956352
[TBL] [Abstract][Full Text] [Related]
13. Vaccination: A durable design.
Sanderson K
Nature; 2012 Aug; 488(7413):S7. PubMed ID: 22932439
[No Abstract] [Full Text] [Related]
14. [Implementation of HPV vaccination in Germany].
Schreckenberger C; Kaufmann AM; Schneider A
Dtsch Med Wochenschr; 2007 Oct; 132(42):2221-4. PubMed ID: 17926251
[No Abstract] [Full Text] [Related]
15. Human papillomavirus vaccine.
Miller NB; Raychaudhuri G; Toerner JG
N Engl J Med; 2007 Sep; 357(11):1154-5; author reply 1155-6. PubMed ID: 17855679
[No Abstract] [Full Text] [Related]
16. One-dose Human Papillomavirus (HPV) vaccine offers solid protection against cervical cancer.
Saudi Med J; 2022 May; 43(5):538. PubMed ID: 35537734
[No Abstract] [Full Text] [Related]
17. HPV vaccine strategies: the cost of HPV and the choice of vaccine.
Morris SR
Sex Transm Infect; 2009 Sep; 85(5):315-6. PubMed ID: 19773455
[No Abstract] [Full Text] [Related]
18. HPV vaccination--more answers, more questions.
Sawaya GF; Smith-McCune K
N Engl J Med; 2007 May; 356(19):1991-3. PubMed ID: 17494933
[No Abstract] [Full Text] [Related]
19. Cost-effectiveness analysis of AS04-adjuvanted human papillomavirus 16/18 vaccine compared with human papillomavirus 6/11/16/18 vaccine in the Philippines, with the new 2-dose schedule.
Germar MJ; Purugganan C; Bernardino MS; Cuenca B; Chen YC; Li X; Van Kriekinge G; Lee IH
Hum Vaccin Immunother; 2017 May; 13(5):1158-1166. PubMed ID: 28075249
[TBL] [Abstract][Full Text] [Related]
20. Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.
Vetter KM; Geller SE
J Womens Health (Larchmt); 2007 Nov; 16(9):1258-68. PubMed ID: 18001182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
